Skip to main content
SpringerLink
Log in

Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review

  • Review Articles
  • Published:
Pharmaceutisch Weekblad Aims and scope Submit manuscript

Abstract

Since its introduction some years ago continuous ambulatory peritoneal dialysis (CAPD) has proved to be a valuable alternative to haemodialysis in the treatment of uraemia. Factors contributing to the transport of solutes through the peritoneal membrane are discussed and the literature concerning the pharmacokinetic aspects of CAPD is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978;88:449–56.

    PubMed  Google Scholar 

  2. Rubin J, Rogers WA, Taylor HM, et al. Peritonitis during continuous peritoneal dialysis. Ann Intern Med 1980;92:7–13.

    PubMed  Google Scholar 

  3. Wu G. A review of peritonitis episodes that caused interruption of CAPD. Perit Dial Bull 1983;3:S11–S3.

    Google Scholar 

  4. Fenton SS. Peritonitis-related deaths among CAPD-patients. Perit Dial Bull 1983;3:S9–S11.

    Google Scholar 

  5. Fenton SS, Wu G, Cattran D, et al. Clinical aspects of peritonitis in patients of CAPD. Perit Dial Bull 1981;1:S54–S7.

    Google Scholar 

  6. Manuel MA, Paton TW, Cornish WR. Drugs and peritoneal dialysis. Perit Dial Bull 1983:3:117–25.

    Google Scholar 

  7. Maher JF. Transport kinetics in peritoneal dialysis. Perit Dial Bull 1982;2:S4–S6.

    Google Scholar 

  8. Maher JF. Transport kinetics of drugs and peritoneal dialysis. In: Gahl GM, Kessel M, Nolph KD, eds. Advances in peritoneal dialysis. Proceedings of the Second International Symposium on Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981:37–40.

    Google Scholar 

  9. Maher JF, Hirszel P, Lasrich M. An experimental model for study of pharmacologic and hormonal influences on peritoneal mass transport. Contrib Nephrol 1979;17:131–8.

    PubMed  Google Scholar 

  10. Maher JF, Hirszel P, Lasrich M. Prostaglandin effects on peritoneal transport. In: Gahl GM, Kessel M, Nolph KD, eds. Advances in peritoneal dialysis. Proceedings of the Second International Symposium on Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981:65–72.

    Google Scholar 

  11. Maher JF, Hirszel P, Abraham JE, Galen MA, Chamberlin M, Hohnadel DC. Effect of dipyridamole on peritoneal mass transport. Trans Am Soc Artic Intern Organs 1977;23:219–23.

    Google Scholar 

  12. Nolph KD, Twardowski ZJ, Popovich RP, Rubin J. Equilibration of peritoneal dialysis solutions during long-dwell exchanges. J Lab Clin Med 1979;93:246–56.

    PubMed  Google Scholar 

  13. Twardowski ZJ, Ksiazek A, Majdan M, et al. Kinetics of CAPD with four exchanges per day. Clin Nephrol 1981;15:115–30.

    PubMed  Google Scholar 

  14. Randerson DH, Farell PC. Mass transfer properties of the human peritoneum. Am Soc Artific Intern Org J 1980;3:140–6.

    Google Scholar 

  15. Paton TW, Manuel MA, Walker SE. Tobramycin disposition in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982:2:179–81.

    Google Scholar 

  16. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Pharmacokinetics of tobramycin in continuous ambulatory peritoneal dialysis. Clin Res 1982;30:717A.

    Google Scholar 

  17. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Tobramycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;34:110–6.

    PubMed  Google Scholar 

  18. Blouin RA, Bauer LA, Piecoro JJ, Holland NH. Decreased gentamicin half-life during peritoneal dialysis. Drug Intell Clin Pharm 1980;14:218–9.

    Google Scholar 

  19. Somani P, Shapiro RS, Stockard H, Higgins JT. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1982;32:113–21.

    PubMed  Google Scholar 

  20. Paton TW, Manuel MA, Cohen LB, Walker SE. The disposition of cefazolin and tobramycin following intraperitoneal administration in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 1983;3:73–6.

    Google Scholar 

  21. Königshausen T, Nachtigall W, Pützhofen G, Rosin H. Pharmacokinetics of lamoxactam in patients using continuous ambulatory peritoneal dialysis. In: Spitzy KH, Karrer K, eds. Proceedings of the 13th international congress of chemotherapy. Part 80. Vienna: Egermann, 1983:7–10.

    Google Scholar 

  22. Thomae U, Boos W, Adam D. Transperitoneale Resorption von Ampicillin, Cefuroxim und Gentamicin unter kontinuierlicher ambulanter Peritonealdialyse. Med Welt 1982;33:182–4.

    PubMed  Google Scholar 

  23. Thomae U, Boos W, Adam D. Transperitoneale Resorption von Oxacillin, Azlocillin und Sisomicin unter kontinuierlicher ambulanter Peritonealdialyse bei Patienten mit und ohne Peritonitis. Med Welt 1981;32:1365–7.

    PubMed  Google Scholar 

  24. Pancorbo S, Comty C. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis. Nephron 1982;31:37–9.

    PubMed  Google Scholar 

  25. Bunke C, Aronoff G, Brier M, Sloan R, Luft F. Pharmacokinetics of vancomycin in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;33:263.

    Google Scholar 

  26. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;34:631–7.

    PubMed  Google Scholar 

  27. Matzke GR, Halstenson CE, Blevins RB, Salem NG. Pharmacokinetics of vancomycin during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;33:236.

    Google Scholar 

  28. Talbert RL, Brochway BA, Ludden TM. Vancomycin clearance during chronic ambulatory peritoneal dialysis. Drug Intell Clin Pharm 1983;17:442–3.

    Google Scholar 

  29. Brumfitt W, Hamilton-Miller J, Gooding A. Pharmacokinetics of rifampin and trimethoprim during peritoneal dialysis. In: Periti P, Grassi GG, eds. Proceedings of the 12th international congress of chemotherapy Vienna: Egermann, 953–4.

  30. Matzke GR, Halstenson CE, Blevins RB, Salem NG. Trimethoprim-Sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;33:235.

    Google Scholar 

  31. Glasson P, Favre H. Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole. Nephron 1984;36:65–7.

    PubMed  Google Scholar 

  32. Kerr CM, Perfect JR, Craven PC, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 1983;99:334–7.

    PubMed  Google Scholar 

  33. Chapman JR, Warnock DW. Ketoconazole and fungal CAPD peritonitis. Lancet 1983;2:510–1.

    Article  Google Scholar 

  34. Muther RS, Bennet WM. Peritoneal clearance of amphotericin B and 5-fluorocytosine. West J Med 1980;133:157–60.

    PubMed  Google Scholar 

  35. Lempert KD, Jones JM. Flucytosine-miconazole treatment of Candida peritonitis. Arch Intern Med 1982;142:577–8.

    Article  PubMed  Google Scholar 

  36. Khanna R, Oreopoules DG, Vas S, McCready W, Dombros N. Fungal peritonitis in patients undergoing chronic intermittent or continuous ambulatory peritoneal dialysis. Proc EDTA, 1980;17:291–6.

    Google Scholar 

  37. Paton TW, Manuel MA, Walker SE. Cimetidine disposition in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982;2:73–6.

    Google Scholar 

  38. Hyneck ML, Murphy JF, Lipschutz DE. Cimetidine clearance during intermittent and chronic peritoneal dialysis. Am J Hosp Pharm 1981;38:1760–2.

    PubMed  Google Scholar 

  39. Kogan FJ, Sampliner RE, Mayersohn M, et al. Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis. J Clin Pharmacol 1983;23:252–6.

    PubMed  Google Scholar 

  40. Pizella KM, Moore MC, Schultz RW, Walshe J, Schentag JJ. Removal of cimetidine by peritoneal dialysis, hemodialysis and charcoal hemoperfusion. Ther Drug Monit 1980;2:273–81.

    PubMed  Google Scholar 

  41. Vaziri ND, Ness RL, Barton CH. Peritoneal dialysis clearance of cimetidine. Am J Gastroenterol 1979;71:572–6.

    PubMed  Google Scholar 

  42. Bodemar G, Norlander B, Walan A. Pharmacokinetics of cimetidine after single doses and during continuous treatment. Clin Pharmacokinet 1981;6:306–15.

    PubMed  Google Scholar 

  43. Pancorbo S, Comty C. Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1981;19:605–7.

    PubMed  Google Scholar 

  44. Pancorbo S, Comty C. Pharmacokinetics of cefamandole in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Bull 1983;3:135–8.

    Google Scholar 

  45. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;33:66–72.

    PubMed  Google Scholar 

  46. Matoušovic K, Morávek J, Vitko S, et al. Pharmacokinetics of intravenous and intraperitoneal cefotaxim in patients undergoing CAPD. In: Spitzy KH, Karrer K, eds. Proceedings of the 13th international congress of chemotherapy. Part 80. Vienna: Egermann, 1983:11–4.

    Google Scholar 

  47. Greaves WL, Kreeft JH, Ogilvie RI, Richards GK. Cefoxitin disposition during peritoneal dialysis. Antimicrob Agents Chemother 1981;19:253–5.

    PubMed  Google Scholar 

  48. Comstock TJ, Straughn AB, Kraus AP, Meyer MC, Finn AL, Chubb JM. Ceftazidime pharmacokinetics during continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis. Drug Intell Clin Pharm 1983;17:453.

    Google Scholar 

  49. Somani P, Gross ML, Freimer EH, Nally JV, Higgins JT. Ceftizoxime exchange through the peritoneal membrane in renal patients. Clin Pharmacol Ther1983;33:265.

    Google Scholar 

  50. Blair AD, Burgess ED. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;33:249.

    Google Scholar 

  51. Burgess ED, Blair AD. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1983;24:237–9.

    PubMed  Google Scholar 

  52. Gross ML, Freimer EH, Somani P. Pharmacokinetics and peritoneal clearance of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. Clin Res 1982;30:753A.

    Google Scholar 

  53. Gross ML, Somani P, Ribner BS, Raeder RH, Freimer EH. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis. In: Spitzy KH, Karrer K, eds. Proceedings of the 13th international congress of chemotherapy. Part 80. Vienna: Egermann, 1983:3–5.

    Google Scholar 

  54. Gross ML, Somani P, Ribner BS, et al. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;34:673–80.

    PubMed  Google Scholar 

  55. Singlas E, Boutron HF, Merdjan H, Brocard JF, Pocheville M, Fries D. Moxalactam kinetics during chronic ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983;34:403–7.

    PubMed  Google Scholar 

  56. Paton TW, Manuel MA, Walker SE. Cimetidine disposition in continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1981;29:271.

    Google Scholar 

  57. De Paoli Vitali E, Casol D, Tessarin C, Tisoni GF, Cavagna R. Pharmacokinetics of digoxin in CAPD. In: Gahl GM, Kessel M, Nolph KD, eds. Advances in peritoneal dialysis. Proceedings of the Second International Symposium on Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981:85–7.

    Google Scholar 

  58. Lameire N, Belpaire F, Bogaert M, et al. A review and studies on digoxin and gentamicin in peritoneal dialysis. In: Atkins RC, Thompson NM, Farrell PC, eds. Edinburgh: Churchill Livingstone, 1981:30–40.

    Google Scholar 

  59. DePaepe M, Belpaire F, Bogaerts Y. Pharmacokinetics of digoxin in CAPD. Clin Exp Dial Apheresis 1982;6:65–73.

    PubMed  Google Scholar 

  60. Pancorbo S, Comty C. Digoxin pharmacokinetics in continuous peritoneal dialysis. Ann Intern Med 1980;93:639.

    Google Scholar 

  61. Risler T, Peters U, Passlick J, Grabensee B, Krokou J. Pharmacokinetics of digoxin and digitoxin in patients on continuous ambulatory peritoneal dialysis. In: Gahl GM, Kessel M, Nolph KD, eds. Advances in peritoneal dialysis. Proceedings of the Second International Symposium on Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981:88–9.

    Google Scholar 

  62. Chin TW, Pancorbo S, Comty C. Quinidine pharmacokinetics in continuous ambulatory peritoneal dialysis. Clin Exp Dial Apheresis 1981;5:391–7.

    PubMed  Google Scholar 

  63. Boutron HF, Brocard JF, Singlas E, Charpentier B, Fries D. Pharmacokinetics of furosemide in CAPD. In: Gahl GM, Kessel M, Nolph KD, eds. Advances in peritoneal dialysis. Proceedings of the Second International Symposium on Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981:90–2.

    Google Scholar 

  64. Hess B, Keusch G, Flückiger J, Binschwanger U. Zur Pharmacokinetik von Phenytoin bei kontinuierlicher ambulanter Peritonealdialyse. Schweiz Med Wochenschr 1984;114:16–9.

    PubMed  Google Scholar 

  65. DePaepe M, Lameire N, Ringoir S, Belpaire F, Bogaert M. Peritoneal pharmacokinetics of gentamicin in man and rabbit. In: Gahl GM, Kessel M, Nolph KD, eds. Advances in peritoneal dialysis. Proceedings of the Second International Symposium on Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981:99–101.

    Google Scholar 

  66. DePaepe M, Lameire N, Belpaire F, Bogaert M. Peritoneal pharmacokinetics of gentamicin in man. Clin Nephrol 1983;19:107–9.

    PubMed  Google Scholar 

  67. Dahlager JI, Ekelund B. Netilmicin in treatment of peritonitis in patients on continuous ambulatory dialysis. In: Spitzky KH, Karrer K, eds. Proceedings of the 13th international congress of chemotherapy. Part 80. Vienna: Egermann, 1983:24–7.

    Google Scholar 

  68. Lewis DA, Chapman ST, Kingswood JC, White LO, Banks RA, Reeves DS. Pharmacokinetics of cefotaxime in continuous ambulatory peritoneal dialysis. In: Spitzky KH, Karrer K, eds. Proceedings of the 13th international congress of chemotherapy. Part 80. Vienna: Egermann, 1983:15–8.

    Google Scholar 

  69. Petersen J, Stewart RD, Catto GR, Edward N, Ratcliffe P. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in CAPD patients. In: Spitzky KH, Karrer K, eds. Proceedings of the 13th international congress of chemotherapy. Part 80. Vienna: Egermann, 1983:19–23.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Medical Centre Alkmaar, Van Everdingenstraat 18, 1814, HA Alkmaar, The Netherlands

    R. Janknegt & C. H. W. Koks

Authors
  1. R. Janknegt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. H. W. Koks
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janknegt, R., Koks, C.H.W. Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review. Pharmaceutisch Weekblad Scientific Edition 6, 229–236 (1984). https://doi.org/10.1007/BF01954550

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01954550

Keywords

Search

Navigation